After making its mark as the first therapy approved for pseudobulbar affect (pathologic laughing and crying) in ALS and MS, Nuedexta is under study for additional uses in a range neurologic diseases.
Specialized software now combines multiparametric MRI and transrectal ultrasound images to improve targeted biopsy of suspicious lesions. The technology has the potential to significantly improve localization and characterization of prostate cancer when added to a 12-core biopsy.
Median arcuate ligament syndrome is controversial because of its lack of proved mechanism. The main evidence for it is patients’ relief following release of the median arcuate ligament — typically after a long, agonizing diagnostic journey.
Discover how Cleveland Clinic physicians are hoping to improve survival in uveal melanoma by identifying patients with micrometastases—and suppressing them before they progress to macrometastases.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A new technique developed by Cole Eye Institute’s Elias Traboulsi, MD, has been shown to improve surgical outcomes for the roughly 5 percent of patients with thyroid eye disease who require strabismus surgery.
Nausea and vomiting are common in advanced cancer and lead to significant reduction in quality of life. In-depth assessment of each patient and systematic use of several drug classes can reduce the symptoms.
Dr. Stanley Hazen’s long-term studies of HDL are profoundly altering our view of HDL and its role in heart disease — and may soon yield a diagnostic assay for cardiac risk based on the new insights.
There’s no arguing that rhBMP-2 forms bone. The latest research aims to learn whether its adverse effects outweigh its benefits, and in which types of spine fusion procedures the risk-benefit ratio is most favorable.
Amputation can often be avoided by taking a multidisciplinary, state-of-the-art approach to limb revascularization that includes addressing underlying risk factors.
Low-grade inflammation in celiac disease doubles the risk of coronary artery disease in patients of any age.